A Wealth of Experience

We have collaborated with our clients on projects to research ocular disease, ocular treatment, and complications and comorbidities of ocular disease.  Our experience includes:

  • Benign essential blepharospasm (BEB)
  • Cataract surgery
  • Conjunctivitis
  • Diabetic macular edema
  • Diabetic retinopathy
  • Dry eye
  • Glaucoma
  • Macular degeneration
  • Nonarteritic anterior ischemic optic neuropathy (NAION)
  • Ocular hypertension
  • Ocular complications of graft-versus-host disease (GVHD)
  • Posterior blepharitis

Types of Projects

We have implemented studies to help our client develop strategies in the ophthalmology market and to develop and gain market access for product to treat ocular diseases and complications arising from treatment of ocular diseases. Recent projects have included: 

Our Experts

Ryan Ziemiecki
Director, Biostatistics
William L Herring
Senior Director, Health Economics
Katherine Houghton
Director, Health Economics
Annete Njue
Senior Director, Market Access and Outcomes Strategy
Susan Martin
Executive Director, Patient-Centered Outcomes Assessment
Elena Rivero
Senior Director, Epidemiology
Stephanie Earnshaw
Senior Vice President, Health Economics
Christopher N. Graham
Senior Director, Health Economics
Joan Fortuny
Director, Epidemiology
Dee Dee Mladsi (she/her)
Vice President, Health Economics—Strategy and Early Modeling
Sandy Lewis
Senior Director, Patient-Centered Outcomes Assessment
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Jin Yang
Associate Director, Market Access and Outcomes Strategy
Sorrel Wolowacz
Head, European Health Economics
Anne Heyes
Vice President, Head Market Access and Outcomes Strategy, Europe
Anita Brogan
Vice President, Decision Analytic Modeling, Health Economics

Selected Recent Ophthalmology Publications